| 24.84 -0.66 (-2.59%) | 04-25 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 32.18 | 1-year : | 35.33 |
| Resists | First : | 27.55 | Second : | 30.25 |
| Pivot price | 25.51  |
|||
| Supports | First : | 23.19 | Second : | 19.29 |
| MAs | MA(5) : | 24.71  |
MA(20) : | 26.2 |
| MA(100) : | 30.61 |
MA(250) : | 32.76 |
|
| MACD | MACD : | -1.3 |
Signal : | -1.3 |
| %K %D | K(14,3) : | 42.6 |
D(3) : | 34.1 |
| RSI | RSI(14): 38.3 |
|||
| 52-week | High : | 45.79 | Low : | 22.04 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SGRY ] has closed above bottom band by 36.7%. Bollinger Bands are 18.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 25.44 - 25.57 | 25.57 - 25.65 |
| Low: | 24.23 - 24.4 | 24.4 - 24.5 |
| Close: | 24.6 - 24.85 | 24.85 - 25.02 |
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Wed, 24 Apr 2024
Should You Invest in Surgery Partners (SGRY)? - Yahoo Canada Finance
Wed, 24 Apr 2024
Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion - Simply Wall St
Sat, 20 Apr 2024
Surgery Partners (NASDAQ:SGRY) shareholders are still up 108% over 5 years despite pulling back 3.7% in the past ... - Yahoo Movies Canada
Fri, 19 Apr 2024
Surgery Partners feeling no pinch from macroeconomic weakness - MSN
Mon, 15 Apr 2024
Surgery Partners Enters Oversold Territory (SGRY) - Nasdaq
Wed, 06 Mar 2024
Insider Sell: CFO David Doherty Sells 3,426 Shares of Surgery Partners Inc (SGRY) - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 127 (M) |
| Shares Float | 74 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 107.6 (%) |
| Shares Short | 8,270 (K) |
| Shares Short P.Month | 7,760 (K) |
| EPS | -0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 15.78 |
| Profit Margin | -0.5 % |
| Operating Margin | 19.8 % |
| Return on Assets (ttm) | 3.8 % |
| Return on Equity (ttm) | 4 % |
| Qtrly Rev. Growth | 4 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 21.64 |
| EBITDA (p.s.) | 4.2 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 294 (M) |
| Levered Free Cash Flow | 143 (M) |
| PE Ratio | -276 |
| PEG Ratio | 0.5 |
| Price to Book value | 1.57 |
| Price to Sales | 1.14 |
| Price to Cash Flow | 10.7 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|